Temporomandibular Joint Dysfunction Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 18 years or older; both sexes; diagnosis of temporomandibular dysfunction by the Diagnostic Criteria; completion of the free and informed consent form; change in heart rate variability with sympathetic or parasympathetic index outside the normal range (-1 to 1), in at least 2 of the 3 orthotest moments; minimum pain level of 4 considering an average of 4 values: greatest pain in the last week, least pain in the last week, average pain in the last week and current pain, all on a visual analogue scale from 0 to 10
Exclusion criteria
Exclusion criteria: Neurological impairment; rheumatological diseases such as rheumatoid arthritis and ankylosing spondylitis; cardiac arrhythmia or other cardiovascular conditions using beta-blockers; pregnant women or women who are breastfeeding; patients diagnosed with cancer; epilepsy; skull, cervical or rib fractures; severe osteoporosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to assess the feasibility of the study through the recruitment rate, adherence rate, acceptability of the intervention, safety of the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| An improvement in heart rate variability towards normal parameters is expected in the intervention group, assessed before and after the end of the intervention protocol using orthotest;A decrease in pain intensity is expected in the intervention group, assessed before and after the end of the intervention protocol, as well as maintenance of this improvement 30 days later, assessed using the visual numerical scale, with follow-up carried out by telephone;An increase in the pressure pain threshold in the masseter is expected, assessed before and after the end of the intervention protocol using algometry;An improvement in sleep quality is expected in the intervention group, assessed before and after the end of the intervention protocol, as well as maintenance of this improvement 30 days later, assessed using the Pittsburg questionnaire, with follow-up carried out by telephone;An improvement in nonspecific physical symptoms is expected in the intervention group, assessed before and after the end of the intervention protocol, as well as maintenance of this improvement 30 days later, assessed through the Patient Health Questionnaire - 15 questions, with follow-up carried out by telephone;An improvement in anxiety, depression and stress is expected in the intervention group, assessed before and after the end of the intervention protocol, as well as maintenance of this improvement 30 days later, assessed using the Depression, Anxiety and Stress Scale, with follow-up carried out by telephone | — |
Countries
Brazil
Contacts
Universidade Federal do Espírito Santo